GTF2F2P2

Across TCGA pan-cancer cohorts, GTF2F2P2 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated GTF2F2P2 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher GTF2F2P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GTF2F2P2 expression acts as an unfavorable survival marker, although some lineages such as ESCA and GBM show a favorable association.

LIHC, BLCA, and THCA are the cancer types where GTF2F2P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	III,IV	0.229	0.665	<.001	81	view →
BLCA	DFS	Tertile	III,IV	0.191	0.513	.001	72	view →
THCA	OS	Tertile	All	0.223	0.950	<.001	45	view →
ESCA	OS	Tertile	III,IV	0.889	0.355	.008	36	view →
CESC	OS	Tertile	II,III,IV	0.289	0.619	.027	36	view →
GBM	OS	Tertile	All	0.405	0.221	.009	30	view →
KICH	OS	Tertile	III,IV	0.153	0.729	.008	27	view →
MESO	DFS	Tertile	III,IV	0.202	0.427	.023	27	view →
HNSC	DFS	Tertile	III,IV	0.186	0.513	.013	27	view →
PAAD	OS	Tertile	All	0.199	0.548	.023	24	view →
LAML	DFS	Tertile	All	0.194	0.536	.002	18	view →
READ	OS	Tertile	IV	0.386	0.741	.037	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

GTF2F2P2–LIHC (OS)

Open the LIHC breakdown →